Cardiovascular complications in patients with diabetic nephropathy receiving pharmacological versus renal replacement therapy

Polskie Archiwum Medycyny Wewnetrznej

Volumn 118, Issue 7-8, 2008, Pages 404-412

  Głowińska, Irena ^a,b   Grochowski, Janusz ^a   Małyszko, Jolanta ^b,c  

^a Dialysis Center   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^c Samodzielny Publiczny Dzieci cy Szpital Kliniczny   (Poland)

Author keywords

Arterial hypertension; Chronic heart failure; Coronary artery disease; Diabetic nephropathy; Peripheral arterial obstructive disease

Indexed keywords

CALCIUM PHOSPHATE; CREATININE; ELECTROLYTE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BLOOD GAS; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE CLASSIFICATION; ELECTROCARDIOGRAM; FEMALE; GLOMERULUS FILTRATION RATE; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE HYPERTROPHY; HEMODIALYSIS; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT ASSESSMENT; RENAL REPLACEMENT THERAPY; UREA NITROGEN BLOOD LEVEL;

EID: 49249094541     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.434     Document Type: Article

References (35)

1. Amann K, Wiest G, Klaus G. The role of parathyroid hormone in the genesis of interstitial cell activation in uraemia. J Am Soc Nephrol. 1994; 4: 1814-1819.
2. de Zeeuw D. Albuminuria: a target for treatment of type 2 diabetic nephropathy. Semin Nephrol. 2007; 27: 172-181.
3. Ritz E. Diabetic nephropathy. Saudi J Kidney Dis Transpl. 2006; 17: 481-490.
4. Schram MT, Chaturvedi N, Schalkwijk CG. Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes - The EURODIAB Prospective Complications Study. Diab Care. 2003; 26: 2165-2173.
5. Mitsnefes MM, Daniels SR, Schwartz SM. Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol. 2000; 14: 898-902.
6. Reis SE, Olson MB, Fried L. Mild renal insufficiency is associated with angiographic coronary disease in women. Circulation. 2002; 105: 2826-2827.
7. Johnstone LM, Jones CL, Grigg LE. Left ventricular abnormalities in children, adolescents and young adults with renal disease. Kidney Int. 1996; 50: 998-1006.
8. Levin A, Singer J, Thompson CR. Prevalent left ventricular hypertrophy in the predialysis population:identifying opportunities for intervention. Am J Kidney Dis. 1996; 27: 347-354.
9. Ritz E. Heart and kidney: fatal twins. Am J Med. 2006; 119 (Suppl. 1): S31-39.
10. Schiliaci G, Reboldi G, Verdecchia P. High normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension. Arch Intern Med. 2001; 161: 886-891.
11. Mallamaci F, Zoccali C, Parlongo S. Troponin is related to left ventricular mass and predicts all-couse and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2002; 40: 68-75.
12. Blacher J, Demuth K, Guerin AP. Association between plasma homocysteine concentrations and cardiac hypertrophy in end-stage renal disease. J Nephrol. 1998; 12: 248-255.
13. Zoccali C, Mallamaci F, Benedetto F. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in hemodialysis patients. J Am Soc Nephrol. 2001; 12: 1508-1515.
14. Zoccali C, Maliamaci F, Maas R. Left ventricular hypertrophy, cardiac remodelling and asymetric dimethylarginine (ADMA) in hemodialysis patients. Kidney Int. 2002; 62: 339-345.
15. Demuth K, Blacher J, Guerin AP. Endothellin and cardiovascular remodelling in end-stage renal disease. Nephrol Dial Transpl. 1998; 13: 375-383.
16. Ritz E. Anemia and diabetic nephropathy. Curr Diab Rep. 2006; 6: 469-472.
17. Gupta A, Kallenbach LR, Zasuwa G. Race is a major determinant of secondary hyperparathyroidism in uremic patients. J Am Soc Nephrol. 2000; 11: 330-334.
18. Schoming M, Ritz E. Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites. Nephrol Dial Transpl. 2000; 15 (suppl. 5): 18.
19. Howard BV, Magee MF. Diabetes and cardiovascular disease. Curr Atheroscler Rep. 2000; 2: 476-481.
20. Laakso M. Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention. J Intern Med. 2001; 249: 225-235.
21. Ritz E, Wanner C. Lipid changes and statins in chronic renal insufficiency. J Am Soc Nephrol. 2006; 17 (Suppl 3): S226-230.
22. Levin A, Thompson CR, Ethier J. Left ventricular mass index increase in early renal disease:impact of decline in hemoglobin. Am J Kidney Dis. 1999; 34: 125-134.
23. Marchais SJ, Guerin AP, Pannier B. Wave reflections and cardiac hypertrophy in chronic uremia: role of arterial wave reflections. Hypertension. 1193; 22: 876-883.
24. Guerin AP, Pannier B, Marchais SJ. Arterial remodeling and cardiovascular function in end-stage renal disease. Adv Nephrol. 1998; 27: 105-109.
25. Mancia G, de Backer G, Dominiczak A. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007; 25: 1105-1187.
26. Zapolski T, Wysokiński A, Janicka L. Sztywność aorty oraz zwapnienia zastawek serca u chorych z przewlekła̧ niewydolnościa̧ nerek. Pol Arch Med Wewn. 2008; 118: 111-118.
27. Ribeiro S, Ramos A, Brandao A. Cardiac valve calcification in haemodialysis patients:role of calcium-phosphate metabolizm. Nephrol Dial Transpl. 1998; 13: 2037-2040.
28. Mazzaferro S, Coen G, Bandini S. Role of ageing, chronic renal failure and dialysis in the calcification of the mitral annulus. Nephrol Dial Transpl. 1993; 8: 335-340.
29. London GM, Pannier B, Marchais SJ. Calcification of the aortic valve in the dialyzed patients. J Am Soc Nephrol. 2000; 11: 778-783.
30. Goodman WG, Salusky IB. Non-invasive assessments of cardiovascular disease in patients with renal failure. Curr Opin Nephrol Hypertens. 2001; 10: 365-369.
31. Levin A, Djurdjev O, Barrett B. Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter. Am J Kid Dis. 2001; 38: 1398-1407.
32. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. New Engl J Med. 1998; 339: 799-805.
33. Foley RN, Parfrey PS. Cardiac disease in the diabetic dialysis patient. Nephrol Dial Transplant. 1998; 13: 1112-1113.
34. Hillege HL, Girbes AR, de Kam PJ. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 2000; 102: 203-210.
35. Veres A, Akbari CM, Primavera J. Endothelial dysfunction and the expression of endothelial nitric oxide synthase in diabetic neuropathy, vascular disease and foot ulceration. Diabetes. 1998; 47: 457-463.